| Original language | English (US) |
|---|---|
| Pages (from-to) | S61-S63 |
| Journal | Neurology |
| Volume | 76 |
| Issue number | 7 SUPPL. 2 |
| DOIs | |
| State | Published - Feb 15 2011 |
| Externally published | Yes |
ASJC Scopus subject areas
- Clinical Neurology
Access to Document
Other files and links
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Neurology, Vol. 76, No. 7 SUPPL. 2, 15.02.2011, p. S61-S63.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - Acalculia in autopsy-proven corticobasal degeneration
AU - Pantelyat, Alexander
AU - Dreyfuss, Michael
AU - Moore, Peachie
AU - Gross, Rachel
AU - Schuck, Theresa
AU - Irwin, David
AU - Trojanowski, John
AU - Grossman, Murray
N1 - Funding Information: Disclosure: Dr. Pantelyat, M. Dreyfuss, and Dr. Moore report no disclosures. Dr. Gross has received research fellow/trainee support from the American Academy of Neurology Foundation. T. Schuck receives research support from the NIH (NIA, NINDS) and from Marian S. Ware Drug Discovery. Dr. Irwin has received research fellow/trainee support from the NIH/NIA. Dr. Trojanowski has received funding for travel and honoraria from Takeda Pharmaceutical Company Ltd.; has received speaker honoraria from Pfizer Inc.; serves as an Associate Editor of Alzheimer's & Dementia; may accrue revenue on patents re: Modified avidin-biotin technique, Method of stabilizing microtubules to treat Alzheimer's disease, Method of detecting abnormally phosphorylated tau, Method of screening for Alzheimer's disease or disease associated with the accumulation of paired helical filaments, Compositions and methods for producing and using homogeneous neuronal cell transplants, Rat comprising straight filaments in its brain, Compositions and methods for producing and using homogeneous neuronal cell transplants to treat neurodegenerative disorders and brain and spinal cord injuries, Diagnostic methods for Alzheimer's disease by detection of multiple MRNAs, Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases, Compositions and methods for producing and using homogenous neuronal cell transplants, Method of identifying, diagnosing and treating alpha-synuclein positive neurodegenerative disorders, Mutation-specific functional impairments in distinct tau isoforms of hereditary frontotemporal dementia and parkinsonism linked to chromosome-17: genotype predicts phenotype, Microtubule stabilizing therapies for neurodegenerative disorders, and Treatment of Alzheimer's and related diseases with an antibody; and receives research support from the NIH/NIA and from the Marian S. Ware Alzheimer Program. Dr. Grossman serves on a scientific advisory board for Allon Therapeutics Inc.; serves as Editor of Cognitive and Behavioral Neurology; has served as a consultant for Pfizer Inc. and Forest Laboratories, Inc.; and receives research support from the NIH. Funding Information: Study funding: Supported in part by the NIH (NS44266, AG17586, AG15116, NS53488, AG32953).
PY - 2011/2/15
Y1 - 2011/2/15
UR - http://www.scopus.com/inward/record.url?scp=79951636768&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79951636768&partnerID=8YFLogxK
U2 - 10.1212/WNL.0b013e31820c34ca
DO - 10.1212/WNL.0b013e31820c34ca
M3 - Article
C2 - 21321355
AN - SCOPUS:79951636768
SN - 0028-3878
VL - 76
SP - S61-S63
JO - Neurology
JF - Neurology
IS - 7 SUPPL. 2
ER -